Mar 11, 2025 / 08:30AM GMT
Michael Staheli - PolyPeptide Group AG - Head of Investor Relations and Corporate Communications
I'm joined here by Juan Jose Gonzalez, our CEO; and Marc Augustin, our CFO. Before we start the presentation, I call your attention to our usual disclaimer on slide 2. After the presentation, Juan Jose and Marc will be available to answer your questions that you can either ask over the phone or in writing through the chat functions. And with this, I hand over to Juan Jose.
Juan-Jose Gonzalez - PolyPeptide Group AG - Chief Executive Officer
Thank you, Michael, and good morning, everyone. In 2024 we posted substantial improvements in profitability and cash flow, and the company is well positioned for strong growth. Now there are four key messages from this session.
Number one, we accelerated our revenue growth in the second half of the year. If you look at our performance excluding COVID, the company reduce 7.1% with a second half of the year growth of 9.5%. Now, this growth is driven by the strong performance of our commercial business.
Full Year 2024 PolyPeptide Group AG Earnings Call Transcript
Mar 11, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers